Medical News

RSS

CardioGenics Holdings offers further update on Merck Chimie agreement status

CardioGenics Holdings Inc., a developer of technology and products targeting the IVD segment of the Point-Of-Care (POC) diagnostic market, announced today a further update regarding the status of its agreement with Merck Chimie s.a.s.

12 Mar 2010

PolyMedix presents data from PMX-30063 defensin-mimetic antibiotic compound Phase 1B study at 8th TSIS

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has presented for the first time to the medical community data from its Phase 1B clinical study with its defensin-mimetic antibiotic compound, PMX-30063.

12 Mar 2010

Amnesty International: Office of Maternal Health need to be established to reduce maternal deaths nationwide

Amnesty International called on President Obama today to quickly establish an Office of Maternal Health to lead government action to reduce soaring pregnancy-related complications and maternal deaths nationwide. The human rights organization said the government must take immediate steps to stop the loss of two to three women every day and reduce the risk of complications that now affect one-third of all pregnant women -- 1.7 million women a year.

12 Mar 2010

Advaxis develops long-term, room temperature, storage-stable form of its vaccines

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company has developing a long-term, room temperature, storage-stable form of its vaccines. This would replace the current requirement to keep the product frozen at -70o C before use.

12 Mar 2010

TKR relieves pain and improves balance in elderly patients with advanced knee arthritis

Total knee replacement successfully relieves pain and improves function in patients with advanced knee arthritis, according to a study presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The surgery also significantly improves dynamic balance among elderly patients.

12 Mar 2010

Generic Focalin XR patent suit: Intellipharmaceutics International announces settlement

Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).

12 Mar 2010

Sanofi-aventis completes Chattem acquisition

Sanofi-aventis announced today that it has completed its acquisition of 100% of Chattem, Inc., which is now a wholly-owned subsidiary of the sanofi-aventis Group.

12 Mar 2010

Roche Diagnostics purchases NimbleGen microarray workflow assets from BioMicro Systems

Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow. These assets consist of key instrumentation in the comprehensive Roche NimbleGen microarray workflow including the NimbleGen Hybridization Systems (both 4- and 12-bay models).

12 Mar 2010

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Former President Bill Clinton and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, said Wednesday at a Senate Foreign Relations Committee hearing "that U.S. investments in fighting [HIV/]AIDS, malaria and other diseases in underdeveloped nations save lives and play a vital role in improving America's image abroad," the Associated Press reports.

12 Mar 2010

Eisai's Dacogen five-day dosing regimen for treatment of MDS receives FDA approval

Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.

12 Mar 2010

Discovery of novel cellular mechanism may help develop new treatments for cancer

A research team led by the University of Colorado at Boulder has discovered a previously unknown cellular "switch" that may provide researchers with a new means of triggering programmed cell death, findings with implications for treating cancer.

12 Mar 2010

Opinions: Haiti corruption; Financial sector tax, G8 promises; Investing in women

A Washington Post editorial reflects on Haitian President Rene Preval's response to U.S. policy makers' queries "about the perils of corruption and what measures the Haitian government might devise to minimize misuse and theft of the billions of dollars in recovery assistance flowing into the country and the billions more expected" during his visit this week to Washington D.C. "Surprisingly, he seems utterly unprepared to discuss the matter," the editorial notes.

12 Mar 2010

State overhaul fears, rising costs, medical school expansions

The New York Times: "The General Assembly became the first state legislature to approve a measure that bucks any effort by President Obama and Congress to carry out a national health care overhaul in individual states." Numerous Democrats joined the Republican majority to support the measure 80-17 in the House of Delegates (3/10).

12 Mar 2010

Bayer HealthCare Pharmaceuticals' ciprofloxacin DPI granted FDA orphan drug designation for CF treatment

Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients. A similar designation has already been granted by the European Medicines Agency.

12 Mar 2010

Laxai Pharma purchases OSR Solutions CRO for $3.6M

Laxai Pharma, Ltd. today announced that it has completed its first acquisition in the clinical research services space by purchasing all of the assets of OSR Solutions, Inc., a New Jersey based contract research organization, for $3.6 million consisting of the following: $1.5mm in cash, $0.75mm in notes, $0.60mm in assumed liabilities, and 5.6mm common shares of Laxai Pharma, Ltd. -- about 10% of the issued and outstanding common shares at closing. The acquisition was financed by a combination of debt and equity.

12 Mar 2010

KHN column -- Public reverse mortgages and long-term care: Can they work together?

In his latest Kaiser Health News column, Howard Gleckman writes: "Here's the problem: By the time we need long-term care services we often don't have readily available resources to pay for them.

12 Mar 2010

Democrats close to health bill deal as some Democrats - and all Republicans - hold out

Congressional Democrats, reportedly closing in on a final health reform agreement, are seeking to alleviate concerns of reluctant members.

12 Mar 2010

Boston Scientific's Express LD Iliac Premounted Stent System for use in iliac arteries receives FDA approval

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac Premounted Stent System for use in iliac arteries. The Express LD Iliac Stent is the first and only low-profile, premounted, balloon-expandable stent approved by the FDA for use in treating iliac artery disease. The Company said it plans to launch the product immediately in the United States.

12 Mar 2010

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.

12 Mar 2010

Hamilton Health Sciences establishes new research facility

Hamilton's role as one of the world's leading centres in cardiac, vascular and stroke research was amplified today with the grand opening of the David Braley Cardiac, Vascular and Stroke Research Institute at the Hamilton General Hospital site of Hamilton Health Sciences.

12 Mar 2010

Medical News

CardioGenics Holdings offers further update on Merck Chimie agreement status

PolyMedix presents data from PMX-30063 defensin-mimetic antibiotic compound Phase 1B study at 8th TSIS

Amnesty International: Office of Maternal Health need to be established to reduce maternal deaths nationwide

Advaxis develops long-term, room temperature, storage-stable form of its vaccines

TKR relieves pain and improves balance in elderly patients with advanced knee arthritis

Generic Focalin XR patent suit: Intellipharmaceutics International announces settlement

Sanofi-aventis completes Chattem acquisition

Roche Diagnostics purchases NimbleGen microarray workflow assets from BioMicro Systems

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Eisai's Dacogen five-day dosing regimen for treatment of MDS receives FDA approval

Discovery of novel cellular mechanism may help develop new treatments for cancer

Opinions: Haiti corruption; Financial sector tax, G8 promises; Investing in women

State overhaul fears, rising costs, medical school expansions

Bayer HealthCare Pharmaceuticals' ciprofloxacin DPI granted FDA orphan drug designation for CF treatment

Laxai Pharma purchases OSR Solutions CRO for $3.6M

KHN column -- Public reverse mortgages and long-term care: Can they work together?

Democrats close to health bill deal as some Democrats - and all Republicans - hold out

Boston Scientific's Express LD Iliac Premounted Stent System for use in iliac arteries receives FDA approval

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

Hamilton Health Sciences establishes new research facility

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News